Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Janjua, Naveed Zafar ^a,b   Yu, Amanda ^a   Kuo, Margot ^a   Alvarez, Maria ^a   Cook, Darrel ^a   Wong, Jason ^a   Tyndall, Mark W ^a,b   Krajden, Mel ^a,b  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cohort study; Epidemiology; HCV; Hepatitis B; HIV; Screening

Indexed keywords

HEPATITIS C ANTIBODY; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BRITISH COLUMBIA; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ABUSE; EPIDEMIC; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; MIDDLE AGED; MIXED INFECTION; MORTALITY; NEOPLASM; NONHUMAN; PREVALENCE; SOCIAL CLASS; TUBERCULOSIS; ALCOHOLISM; CANADA; CHILD; COINFECTION; COMPLICATION; HIV INFECTIONS; INFANT; MENTAL DISORDERS; ODDS RATIO; PRESCHOOL CHILD; SEROLOGY; SUBSTANCE-RELATED DISORDERS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; CANADA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COINFECTION; EPIDEMICS; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INFANT; MALE; MENTAL DISORDERS; MIDDLE AGED; ODDS RATIO; PREVALENCE; SEROLOGIC TESTS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84978886295     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1683-z     Document Type: Article

References (32)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333-42.
2. Trubnikov M, Yan P, Archibald C. Estimated prevalence of Hepatitis C virus infection in Canada, 2011. CCDR. 2014;40(19):429-42.
3. Communicable Disease Prevention and Control Services. British Columbia Annual Summary of Reportable Diseases 2013. Vancouver: BC Centre for Disease Control; 2014.
4. Yu A, Spinelli JJ, Cook DA, Buxton JA, Krajden M. Mortality among British Columbians testing for hepatitis C antibody. BMC Public Health. 2013;13:291.
5. Simmons B, Saleem J, Heath K, Cooke GS, Hill A. Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response. Clinical Infect Dis. 2015;61(5):730-40.
6. Kohli A, Shaffer A, Sherman A, Kottilil S. Treatment of hepatitis C: a systematic review. JAMA. 2014;312(6):631-40.
7. Canadian Agency for Drugs and Technologies in Health. Holkira (Ombitasvir/Paritaprevir/Ritonavir with Dasabuvir) and Harvoni (Ledipasvir/Sofosbuvir) for Chronic Hepatitis C: A Review of the Clinical Evidence. Canadian Agency for Drugs and Technologies in Health. Ottawa (ON); 2015.
8. Rotermann M, Langlois K, Andonov A, Trubnikov M. Seroprevalence of hepatitis B and C virus infections: Results from the 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey. Health Rep. 2013;24(11):3-13.
9. BC Cancer Agency [creator]. BC Cancer Agency Registry Data (2013). Data Extract. Vancouver, BC: Cancer Agency [publisher]; 2014.
10. British Columbia Ministry of Health [creator]. PharmaNet. Victoria, BC: British Columbia Ministry of Health [publisher]; Data Extract. MOH (2013); 2014. http://www.health.gov.bc.ca/data/.
11. British Columbia Ministry of Health [creator]. Medical Services Plan (MSP) Payment Information File. Victoria, BC: British Columbia Ministry of Health [publisher]; Data Extract. MOH (2013). 2014. http://www.health.gov.bc.ca/data/.
12. British Columbia Ministry of Health [creator]. Discharge Abstract Database (Hospital Separations). Victoria, BC: British Columbia Ministry of Health [publisher]. Data Extract. MOH (2013). 2014. http://www.health.gov.bc.ca/data/.
13. British Columbia Vital Statistics Agency [creator]. Vital Statistics Deaths. Victoria, BC: British Columbia Vital Statistics Agency [publisher]. Data Extract. British Columbia Vital Statistics Agency (2014). 2014.
14. Janjua NZ, Kuo M, Chong M, Yu A, Alvarez M, Cook D, Armour R, Aiken C, Li K, Mussavi Rizi SA et al. Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants. PLoS One. 2016;11(3):e0150176.
15. BC Centre for Disease Control. Management of Specific Diseases: Hepatitis C. In: Communicable Disease Control Manual. Vancouver: BC Centre for Disease Control; 2013.
16. Pampalon R, Hamel D, Gamache P, Philibert MD, Raymond G, Simpson A. An area-based material and social deprivation index for public health in Quebec and Canada. Can J Public Health. 2012;103(8 Suppl 2):S17-22.
17. Environics Analytics. 2011 CensusPlus. Edited by Environics Analytics. Toronto, ON 2013.
18. McGuinness L. BCCDC Enhanced Hepatitis Strain Surveillance System (EHSSS) Site Report 2000-2011. Vancouver: BC Centre for Disease Control; 2014.
19. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-14.
20. Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, Holmberg SD. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160(5):293-300.
21. Galbraith JW, Franco RA, Donnelly JP, Rodgers JB, Morgan JM, Viles AF, Overton ET, Saag MS, Wang HE. Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. Hepatology. 2015;61(3):776-82.
22. Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Ward JW. Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention. Ann Intern Med. 2012;157(11):817-22.
23. Schanzer DL, Paquette D, Lix LM. Historical trends and projected hospital admissions for chronic hepatitis C infection in Canada: a birth cohort analysis. CMAJ Open. 2014;2(3):E139-44.
24. Health Canada. Guidelines and recommendations on the prevention and control of hepatitis C. Can Commun Dis Rep 1995, 21 Suppl 2:1-18, 11-21.
25. Kuo M, Janjua NZ, Burchell AN, Buxton JA, Krajden M, Gilbert M. Decreasing Hepatitis C Incidence Among a Population With Repeated Tests: British Columbia, Canada, 1993-2011. Am J Public Health. 2015;105(8):1604-10.
26. Smith BD, Yartel AK, Krauskopf K, Massoud OI, Brown KA, Fallon MB, Rein DB. Hepatitis C virus antibody positivity and predictors among previously undiagnosed adult primary care outpatients: cross-sectional analysis of a multisite retrospective cohort study. Clin Infect Dis. 2015;60(8):1145-52.
27. Akselrod H, Grau LE, Barbour R, Heimer R. Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population. Am J Public Health. 2014;104(9):1713-21.
28. Klein MB, Rollet KC, Saeed S, Cox J, Potter M, Cohen J, Conway B, Cooper C, Cote P, Gill J et al. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality. HIV Med. 2013;14(1):10-20.
29. Morano JP, Gibson BA, Altice FL. The burgeoning HIV/HCV syndemic in the urban Northeast: HCV, HIV, and HIV/HCV coinfection in an urban setting. PLoS One. 2013;8(5):e64321.
30. Public Health Agency of Canada. Epidemiology of acute hepatitis C infection in Canada: results from the enhanced hepatitis strain surveillance system (EHSSS). 2009.
31. Olmstead AD, Joy JB, Montoya V, Luo I, Poon AF, Jacka B, Lamoury F, Applegate T, Montaner J, Khudyakov Y et al. A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events. Infect Genet Evol. 2015;33:101-9.
32. Janjua NZ, Yu A, Kuo M, Alavi M, Woods R, Alvarez M, Dore G, Tyndall M, Krajden M. Timing of Hepatitis B and C Diagnosis Relative to Hepatocellular Carcinoma Diagnosis in the BC Hepatitis Testers Cohort (BC-HTC). Hepatology. 2015;62(S1):480A.